Skip to main content
logo
LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
3.190
-0.110 (-3.33%)
At close: Oct 20, 2026, 4:00 PM EDT
3.200
+0.010 (0.31%)
Pre-market: Oct 21, 2026, 5:19 AM EDT

LENZ Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
21.4819.09--15-
Revenue Growth
329.50%-----
Gross Profit
19.718.67--15-
Operating Income
-135.66-91.14-58.61-72.43-10.48-6.69
Net Income
-126-82.13-49.77-69.97-10.81-7.56
Earnings Per Share
-4.12-2.85-2.34-35.71-1.14-0.81
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
220292.35209.0365.7944.4418.31
Total Debt
0.570.821.380.330.25-
Net Cash (Debt)
219.43291.53207.6565.4744.1918.31
Net Cash Growth
5.26%40.40%217.19%48.14%141.39%-
Net Cash Per Share
7.1710.129.7633.424.671.96

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-113.91-69.17-59.39-60.38-4.09-5.39
Capital Expenditures
-0.51-0.83-0.47-0.03-0.04-0.01
Free Cash Flow
-114.42-70-59.86-60.41-4.13-5.4
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
91.74%97.81%--100.00%-
Operating Margin
-631.70%-477.46%---69.89%-
Pretax Margin
-586.71%-427.62%---69.76%-
Profit Margin
-586.74%-430.25%---72.07%-
FCF Margin
-532.80%-366.71%---27.52%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
4.6726.23----